Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2023, Vol. 37 ›› Issue (2): 33-38.doi: 10.6040/j.issn.1673-3770.0.2021.542

• 论著 • Previous Articles    

Single-cell sequencing analysis of laryngeal cancer and its microenvironmental metabolism-related target genes

XU Chong, WANG Xiaoting, YI Hongliang   

  1. Department of Otolaryngology-Head and Neck Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China
  • Published:2023-03-30

PDF (PC)

119

Abstract: Objective Single cell sequence was used to find the possible targets of metabolism related small molecular drugs targeted on laryngeal cancer glycolysis and glutaminolysis. Methods R language reanalyzed the results of single cell sequence, cells were classified with TSNE and metabolic related genes expression were measured. Results The target genes of glycolysis in laryngeal cancer include glucose transporters, hexokinase, pyruvate kinase. Genes in glutaminolysis include: Na+ coupled transporter for glutamine, glutaminase, glutamate dehydrogenase 1, malate dehydrogenase, lactate dehydrogenase, isocitrate hydrogenase 2. Conclusion In the process of glycolysis and glutaminolysis exist targets for metabolic drugs and this may be used for the develop of new target drugs.

Key words: Glycolysis, Glutaminolysis, Laryngeal cancer, Single cell sequence

CLC Number: 

  • R739.6
[1] Chen WQ, Zheng RS, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132. doi:10.3322/caac.21338
[2] Solomon B, Young RJ, Rischin D. Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments[J]. Semin Cancer Biol, 2018, 52(Pt 2): 228-240. doi:10.1016/j.semcancer.2018.01.008
[3] Barupal DK, Pinkerton KE, Hood C, et al. Environmental tobacco smoke alters metabolic systems in adult rats[J]. Chem Res Toxicol, 2016, 29(11): 1818-1827. doi:10.1021/acs.chemrestox.6b00187
[4] Vanhove K, Graulus GJ, Mesotten L, et al. The metabolic landscape of lung cancer: new insights in a disturbed glucose metabolism[J]. Front Oncol, 2019, 9: 1215. doi:10.3389/fonc.2019.01215
[5] Dang CV. Links between metabolism and cancer[J]. Genes Dev, 2012, 26(9): 877-890. doi:10.1101/gad.189365.112
[6] Vanhove K, Derveaux E, Graulus GJ, et al. Glutamine addiction and therapeutic strategies in lung cancer[J]. Int J Mol Sci, 2019, 20(2): E252. doi:10.3390/ijms20020252
[7] Zhang J, Pavlova NN, Thompson CB. Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine[J]. EMBO J, 2017, 36(10): 1302-1315. doi:10.15252/embj.201696151
[8] Jin L, Alesi GN, Kang S. Glutaminolysis as a target for cancer therapy[J]. Oncogene, 2016, 35(28): 3619-3625. doi:10.1038/onc.2015.447
[9] Wang JB, Erickson JW, Fuji R, et al. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation[J]. Cancer Cell, 2010, 18(3): 207-219. doi:10.1016/j.ccr.2010.08.009
[10] Song L, Zhang S, Yu S, et al. Cellular heterogeneity landscape in laryngeal squamous cell carcinoma[J]. Int J Cancer, 2020, 147(10): 2879-2890. doi:10.1002/ijc.33192
[11] Luo XM, Zhou SH, Fan J. Glucose transporter-1 as a new therapeutic target in laryngeal carcinoma[J]. J Int Med Res, 2010, 38(6): 1885-1892. doi:10.1177/147323001003800601
[12] Shen LF, Zhao X, Zhou SH, et al. In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1α by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET/CT[J]. Oncotarget, 2017, 8(21): 34709-34726. doi:10.18632/oncotarget.16671
[13] Patra KC, Wang Q, Bhaskar PT, et al. Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer[J]. Cancer Cell, 2013, 24(2): 213-228. doi:10.1016/j.ccr.2013.06.014
[14] Gao Y, Xu D, Yu G, et al. Overexpression of metabolic markers HK1 and PKM2 contributes to lymphatic metastasis and adverse prognosis in Chinese gastric cancer[J]. Int J Clin Exp Pathol, 2015, 8(8): 9264-9271
[15] Mor I, Cheung EC, Vousden KH. Control of glycolysis through regulation of PFK1: old friends and recent additions[J]. Cold Spring Harb Symp Quant Biol, 2011, 76: 211-216. doi:10.1101/sqb.2011.76.010868
[16] Webb BA, Forouhar F, Szu FE, et al. Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations[J]. Nature, 2015, 523(7558): 111-114. doi:10.1038/nature14405
[17] Lee JH, Liu R, Li J, et al. Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis[J]. Nat Commun, 2017, 8(1): 949. doi:10.1038/s41467-017-00906-9
[18] Dey P, Son JY, Kundu A, et al. Knockdown of pyruvate kinase M2 inhibits cell proliferation, metabolism, and migration in renal cell carcinoma[J]. Int J Mol Sci, 2019, 20(22): E5622. doi:10.3390/ijms20225622
[19] James AD, Richardson DA, Oh IW, et al. Cutting off the fuel supply to calcium pumps in pancreatic cancer cells: role of pyruvate kinase-M2(PKM2)[J]. Br J Cancer, 2020, 122(2): 266-278. doi:10.1038/s41416-019-0675-3
[20] Dey P, Kundu A, Sachan, et al. PKM2 knockdown induces autophagic cell death via AKT/mTOR pathway in human prostate cancer cells[J]. Cell Physiol Biochem, 2019, 52(6): 1535-1552. doi:10.33594/000000107
[21] 刘晓晓. PKM2和HIF-1α在喉鳞状细胞癌中的表达及意义[D]. 石家庄: 河北医科大学, 2015.
[22] Zhang Z, Liu R, Shuai Y, et al. ASCT2(SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma[J]. Br J Cancer, 2020, 122(1): 82-93. doi:10.1038/s41416-019-0637-9
[23] Lukey MJ, Greene KS, Erickson JW, et al. The oncogenic transcription factor c-Jun regulates glutaminase expression and sensitizes cells to glutaminase-targeted therapy[J]. Nat Commun, 2016, 7: 11321. doi:10.1038/ncomms11321
[24] Zhang J, Mao S, Guo Y, et al. Inhibition of GLS suppresses proliferation and promotes apoptosis in prostate cancer[J]. Biosci Rep, 2019, 39(6): BSR20181826. doi:10.1042/BSR20181826
[25] Momcilovic M, Bailey ST, Lee JT, et al. Targeted inhibition of EGFR and glutaminase induces metabolic crisis in EGFR mutant lung cancer[J]. Cell Rep, 2017, 18(3): 601-610. doi:10.1016/j.celrep.2016.12.061
[26] Craze ML, El-Ansari R, Aleskandarany MA, et al. Glutamate dehydrogenase(GLUD1)expression in breast cancer[J]. Breast Cancer Res Treat, 2019, 174(1): 79-91. doi:10.1007/s10549-018-5060-z
[27] New M, Van Acker T, Sakamaki JI, et al. MDH1 and MPP7 regulate autophagy in pancreatic ductal adenocarcinoma[J]. Cancer Res, 2019, 79(8): 1884-1898. doi:10.1158/0008-5472.CAN-18-2553
[28] Lu YX, Ju HQ, Liu ZX, et al. ME1 regulates NADPH homeostasis to promote gastric cancer growth and metastasis[J]. Cancer Res, 2018, 78(8): 1972-1985. doi:10.1158/0008-5472.CAN-17-3155
[29] Liu C, Cao J, Lin SC, et al. Malic enzyme 1 indicates worse prognosis in breast cancer and promotes metastasis by manipulating reactive oxygen species[J]. Onco Targets Ther, 2020, 13: 8735-8747. doi:10.2147/OTT.S256970
[30] Zhu YH, Gu L, Lin X, et al. Dynamic regulation of ME1 phosphorylation and acetylation affects lipid metabolism and colorectal tumorigenesis[J]. Mol Cell, 2020, 77(1): 138-149.e5. doi:10.1016/j.molcel.2019.10.015
[31] Guo EL, Guo LH, An CM, et al. Prognostic significance of lactate dehydrogenase in patients undergoing surgical resection for laryngeal squamous cell carcinoma[J]. Cancer Control, 2020, 27(1): 1073274820978795. doi:10.1177/1073274820978795
[32] Li JJ, He Y, Tan ZQ, et al. Wild-type IDH2 promotes the Warburg effect and tumor growth through HIF1α in lung cancer[J]. Theranostics, 2018, 8(15): 4050-4061. doi:10.7150/thno.21524
[33] Dang L, Yen K, Attar EC. IDH mutations in cancer and progress toward development of targeted therapeutics[J]. Ann Oncol, 2016, 27(4): 599-608. doi:10.1093/annonc/mdw013
[1] HUANG Hengfeng, MA Kunpeng, YANG Di, ZHANG Lijun, ZHANG Shenglin. Expression and clinical significance of miR-181b-5P and EPB41L3 protein in laryngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(1): 41-46.
[2] WANG MeiOverview,LI ZhihaiGuidance. Laryngeal cancer stem cells: potential therapeutic targets for overcoming multidrug resistance [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(4): 120-128.
[3] WANG Xiaoting, CHEN Zhengnong, YI Hongliang. Transcriptomic analysis of glutamine deprivation on laryngeal carcinoma cells [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(2): 26-31.
[4] LI Yanjie, JIA Jian, YANG Ping, WAN Baoluo. Study on the value of tumor abnormal protein in clinical diagnosis of laryngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(5): 70-74.
[5] LI Wenjing,LIU Ming. Research progress on the relationship between the C2H2 zinc finger protein family and laryngeal cancer [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(1): 125-130.
[6] . The swallowing function recovery study on tongue flap after horizontal hemilaryngectomy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(5): 127-131.
[7] XU Yuanteng, CHEN Ruiqing, LIN Gongbiao, FANG Xiuling, YU Shujuan, LIANG Xiaohua, ZHANG Rong. Effect of silencing PDCD4 gene on proliferation of Hep-2 cells and the expression of β-catenin by RNA interference technique. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(5): 110-114.
[8] LI Xiaoming, SONG Qi, LI Hongxia, TAO Zhenfeng, SHEN Yupeng, XIAO Shufen. Reconstruction of hypopharyngeal defects after ablation of advanced head and neck squamous carcinoma involving hypophaynx with pectoralis major myocutaneous flap. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(3): 4-9.
[9] SU Tiantian, ZHANG Jia, SUN Zhenfeng. Roles of multidrug resistance proteins P-gp and ABCG2 in laryngocatcinoma and their related signal pathways. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(3): 103-106.
[10] LIN Dan, DONG Wei-da, LU Mei-ping, XING Guang-qian, DONG Jia-di, ZHANG Wei-qiang. The association between rs2910164 G>C polymorphism in pre-microRNA-146a and laryngeal cancer in Jiangsu Han population [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(2): 46-50.
[11] ZHENG Li-you. null [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2012, 26(6): 31-33.
[12] SHI Da-zhi1, LUO Zhi-qiang1， ZHOU Jun2. Expression and significance of serum soluble tumor necrosis factor  receptor  Ⅰ and  Ⅱ in patients with laryngeal cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2010, 24(5): 10-12.
[13] LI Qing-feng, ZHANG Zhong-xiang, ZHANG Guo-kui, LI Qiang. Supraglottic horizontal laryngectomy via supra-anterior commissure approach [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2010, 24(4): 13-15.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd